FDA recommends boxed warning for breast implants

The US Food and Drug Administration on Wednesday released draft guidance recommending a "boxed warning" on labeling materials for breast implants. Boxed warnings, which alert health care providers and consumers to serious risks associated with a drug or device, are the strongest form of warning required by the FDA for labeling.